Source: Eur Respir J, 56 (3) 2000513; 10.1183/13993003.00513-2020
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Stefano Ghio, Valentina Mercurio, Federico Fortuni, Paul R. Forfia, Henning Gall, Ardeschir Ghofrani, Stephen C. Mathai, Jeremy A. Mazurek, Monica Mukherjee, Manuel Richter, Laura Scelsi, Paul M. Hassoun, Khodr Tello. A comprehensive echocardiographic method for risk stratification in pulmonary arterial hypertension. Eur Respir J, 56 (3) 2000513; 10.1183/13993003.00513-2020

Member's Comments

No comment yet.

Related content which might interest you: Novel biomarkers for risk stratification in pulmonary arterial hypertension Source: ERJ Open Res 2015; 1: 00008-2015 Year: 2015 In-depth risk stratification in pulmonary arterial hypertension Source: Virtual Congress 2020 – Updated assessment and treatment of pulmonary arterial hypertension Year: 2020 Risk stratification and medical therapy of pulmonary arterial hypertension Source: Eur Respir J, 53 (1) 1801889; 10.1183/13993003.01889-2018 Year: 2019 Risk assessment in pulmonary arterial hypertension Source: Eur Respir Rev 2016; 25: 390-398 Year: 2016 Risk assessment in pulmonary arterial hypertension Source: Eur Respir J, 51 (3) 1800279; 10.1183/13993003.00279-2018 Year: 2018 Risk assessment in pulmonary arterial hypertension Source: Eur Respir J, 51 (3) 1702606; 10.1183/13993003.02606-2017 Year: 2018 Preoperative pulmonary risk assessment of pulmonary arterial hypertension in patients undergoing cardiac surgery Source: Annual Congress 2010 - Pulmonary circulation II Year: 2010 Risk stratification in pulmonary arterial hypertension using Bayesian analysis Source: Eur Respir J, 56 (2) 2000008; 10.1183/13993003.00008-2020 Year: 2020 Can right ventricle imaging improve risk stratification in pulmonary arterial hypertension? Source: Virtual Congress 2021 – Pulmonary embolism: controversies in management Year: 2021 Towards prognostic biomarkers in pulmonary arterial hypertension Source: Eur Respir J 2012; 39: 799-801 Year: 2012 Risk assessment, prognosis and guideline implementation in pulmonary arterial hypertension Source: Eur Respir J, 50 (2) 1700889; 10.1183/13993003.00889-2017 Year: 2017 Non-invasive hemodynamic assessment in patients with pulmonary hypertension Source: Annual Congress 2008 - Pulmonary arterial hypertension and other pulmonary vascular diseases Year: 2008 Mortality in pulmonary arterial hypertension: prediction by the 2015 European pulmonary hypertension guidelines risk stratification model Source: Eur Respir J, 50 (2) 1700740; 10.1183/13993003.00740-2017 Year: 2017 Pulmonary pressure at rest and during slight exercise might have prognostic relevance in patients at risk for pulmonary arterial hypertension Source: Annual Congress 2008 - Pulmonary arterial hypertension and other pulmonary vascular diseases Year: 2008 Risk assessment in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension Source: Eur Respir J, 53 (6) 1802004; 10.1183/13993003.02004-2018 Year: 2019 Risk assessment, therapy and cardiovascular comorbidity in patients with pulmonary arterial hypertension Source: Virtual Congress 2020 – Clinical evaluation, biomarkers and risk assessment of pulmonary hypertension Year: 2020 Analysis of mortality risk factors in a population with pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension Source: Annual Congress 2010 - Pulmonary hypertension Year: 2010 Risk stratification in pulmonary arterial hypertension (PAH) Source: International Congress 2018 – New trends in the management of pulmonary hypertension Year: 2018 Early recognition of pulmonary arterial hypertension in risk patients using exercise stress echocardiography and right heart catheterisation Source: Eur Respir J 2007; 30: Suppl. 51, 287s Year: 2007 Impact of age and comorbidity on risk stratification in idiopathic pulmonary arterial hypertension Source: Eur Respir J, 51 (5) 1702310; 10.1183/13993003.02310-2017 Year: 2018